REDHILL BIOPHARMA LTD. Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019
REDHILL BIOPHARMA LTD. (RDHL) reported Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019 of $283.20 per share for the 12-month period ending 2022-12-31, per its 20-F filed 2024-04-08.
Discontinued › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019 · last filed 2024-04-08
| Period end | Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019 12 month | Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019 12 month as first filed |
|---|---|---|
| 2022-12-31 | $283.20 20-F · filed 2024-04-08 | $7.08 20-F · filed 2023-04-28 |
| 2021-12-31 | $7.08 20-F · filed 2023-04-28 | |
| 2020-12-31 | $6.38 20-F · filed 2022-03-17 | |
| 2019-12-31 | $6.10 20-F · filed 2021-03-18 | $0.61 20-F · filed 2020-03-04 |
| 2018-12-31 | $0.02 20-F · filed 2020-03-04 |